Davinthra Thillainathan

Stock Analyst at Goldman Sachs

(1.23)
# 3,727
Out of 4,609 analysts
35
Total ratings
38.1%
Success rate
-1.5%
Average return

Stocks Rated by Davinthra Thillainathan

Integral Diagnostics Limited
Jun 1, 2026
Upgraded: Hold
Price Target: $2.10$2.15
Current: $2.20
Upside: -2.27%
Ansell Limited
Apr 7, 2026
Initiated Coverage: Hold
Price Target: $31.80
Current: $34.27
Upside: -7.21%
Fisher & Paykel Healthcare Corporation Limited
Feb 23, 2026
Maintained: Buy
Price Target: $51.25$52.81
Current: $41.88
Upside: +26.10%
ResMed Inc.
Feb 2, 2026
Maintained: Buy
Price Target: $49.30$53.20
Current: $29.83
Upside: +78.34%
CSL Limited
Oct 29, 2025
Maintained: Buy
Price Target: $304.60$212.10
Current: $132.22
Upside: +60.41%
Nanosonics Limited
Sep 25, 2025
Initiated Coverage: Buy
Price Target: $6.94
Current: $3.54
Upside: +96.10%
Ramsay Health Care Limited
Sep 11, 2025
Maintained: Hold
Price Target: n/a
Current: $44.44
Upside: -
Healius Limited
Aug 12, 2025
Maintained: Sell
Price Target: $1.20$0.80
Current: $0.41
Upside: +95.12%
Cochlear Limited
Jun 14, 2025
Maintained: Hold
Price Target: n/a
Current: $126.04
Upside: n/a
Sonic Healthcare Limited
Apr 3, 2025
Initiated Coverage: Buy
Price Target: $32.20
Current: $22.25
Upside: n/a
Initiated Coverage: Hold
Price Target: $3.30
Current: $2.37
Upside: n/a